Topical minocycline for CARP skin condition
Part of Skin clinical trials.
This trial tests a topical antibiotic (minocycline) applied to the skin to see if it helps treat CARP, a common skin condition that causes small, reddish-brown spots. It may be a good option if you have CARP and haven't used oral minocycline recently.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 9 years old or older
- You have been diagnosed with CARP (a skin condition that looks like small, reddish-brown spots)
- You have not taken oral minocycline (a type of antibiotic) in the past 6 months
- You are not pregnant or breastfeeding
- You do not have a history of certain health problems like brain pressure issues, autoimmune diseases, liver or kidney disease, a weak immune system, or an allergy to tetracycline antibiotics
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether the antibiotic minocycline can slow vision loss from retinitis pigmentosa. If you are between 18 and 60 and have some remaining sight, this study may help find a new treatment.
This trial tests a rapamycin cream to see if it helps make port-wine stain treatment work better. It is for children 10 or younger who are already planning to have laser therapy.
This study tests if a cream called tapinarof can improve skin symptoms in people with chronic or subacute cutaneous lupus erythematosus (CLE). The goal is to see if it reduces redness, scaling, and thickness of active lesions.
This trial studies whether rapamycin can reduce problems caused by cervico-facial or chest (mediastinal) lymphatic malformations in children. It may help with pain and swallowing or breathing difficulties when standard “curative” treatment isn’t possible.
This study looks at treatment results for central centrifugal cicatricial alopecia (CCCA), a type of hair loss that causes scarring and permanent hair loss. It will follow African-American women to see how well treatments work for different levels of severity.
This trial tests a small device to help treat psoriasis and atopic dermatitis (a common type of eczema). It may offer a new option for managing your skin condition.
Hear when a new Confluent and Reticulated Papillomatosis (CARP) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.